Allworth Financial’s Journey Medical DERM Stock Holding History

Allworth Financial’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$206	Hold	29	–	–	﹤0.01%	5069
2026 Q2	$206	Buy	+29	New	+$166	﹤0.01%	4956

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geneos Wealth Management Englewood, Colorado $5.32B AUM 16.49% 1-Year Est. Return

Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Allworth Financial's DERM Position: Q3 2026 in Review

Allworth Financial held its Journey Medical (DERM) position steady in Q3 2026 at 29 shares worth $206. The position accounts for ﹤0.01% of the portfolio, ranked #5069.

Allworth Financial first reported a position in DERM in Q2 2026 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

Allworth Financial held 29 shares of Journey Medical worth $206 as of Q3 2026.
Allworth Financial left its Journey Medical share count unchanged in Q3 2026.
Journey Medical made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #5069 holding.
Allworth Financial first reported a position in Journey Medical in Q2 2026 and has held it in 2 quarters since.
24 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.